EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Etiology and Outcomes of Kidney-Limited and Systemic Thrombotic Microangiopathy

Daan P C van Doorn, Rachid Tobal, Myrurgia A Abdul-Hamid, Pieter van Paassen, Sjoerd A M E G Timmermans

Modern Pathology · 2025-04 · 38 (4) · 100690

DOI: 10.1016/j.modpat.2024.100690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2025-04. Verfasst von Daan P C van Doorn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Expert Center for Immune-mediated Kidney Diseases and Vasculitis, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Bi…. Hauptthemen laut MEDLINE: Thrombotic Microangiopathies, Kidney. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca, Alexion Pharmaceuticals Inc, Nierstichting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The syndromes of thrombotic microangiopathy (TMA) are associated with acute kidney injury and end-stage kidney disease. TMAs typically present with thrombocytopenia and microangiopathic hemolytic anemia (ie, systemic TMA). Kidney-limited TMA can occur, although often overlooked and undertreated. In this study, we studied the etiology and outcome of kidney-limited TMA. Patients with TMA on kidney biopsy, either systemic or kidney-limited, were recruited and classified as definite complement-mediated (C-)TMA (ie, ≥1 pathogenic complement gene variant), probable C-TMA (ie, massive ex vivo C5b9 formation without a pathogenic complement gene variant), and non (n)C-TMA (ie, normal ex vivo C5b9 formation). Morphologic features of TMA on kidney biopsy and their clinical correlates were studied. Patients were classified as definite C-TMA (N = 14; 18%), probable C-TMA (N = 21; 27%), or nC-TMA (N = 42; 55%), including 51 (66%) out of 77 patients with kidney-limited TMA. Patients with definite and probable C-TMA often presented with hemolysis (79% and 62% vs 34%; P = .007), glomerular thrombosis (79% and 76% vs 43%), a higher creatinine level (974 and 502 vs 280 μmol/L; P = .001), and a younger age (33 and 33 vs 40 years; P = .029) as compared with nC-TMA. Morphologic features neither defined etiology nor differed between systemic and kidney-limited TMA. Eculizumab improved kidney outcomes in patients with kidney-limited C-TMA but not in those with nC-TMA akin to patients with systemic C-TMA. Kidney outcomes were not affected by chronicity grading on kidney biopsy. Kidney-limited TMA is common in diverse TMAs, including C-TMA. A kidney biopsy is needed to detect TMA at the earliest possible stage of the disease. Morphology does not allow for the identification of etiology, and patients with kidney-limited TMA should therefore be screened for complement dysregulation, having a major impact on treatment and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thrombotic MicroangiopathiesKidneyHumansFemaleMaleMiddle AgedAdultAgedBiopsyYoung Adult

Stichwörter der Autor:innen

chronic kidney diseasecomplementhemolytic uremic syndromekidney biopsythrombotic microangiopathy

Autor:innen und Institutionen

  • Expert Center for Immune-mediated Kidney Diseases and Vasculitis, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht,…
  • Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.

Förderung

  • AstraZeneca
  • Alexion Pharmaceuticals Inc
  • Nierstichting
  • Programa Operacional Temático Factores de Competitividade
  • Maastricht Universitair Medisch Centrum

Zitieren

APA

van Doorn, D. P. C., Tobal, R., Abdul-Hamid, M. A., van Paassen, P., & Timmermans, S. A. M. E. G. (2025). Etiology and Outcomes of Kidney-Limited and Systemic Thrombotic Microangiopathy. Modern Pathology, 38(4), 100690. https://doi.org/10.1016/j.modpat.2024.100690

Vancouver

van Doorn DPC, Tobal R, Abdul-Hamid MA, van Paassen P, Timmermans SAMEG. Etiology and Outcomes of Kidney-Limited and Systemic Thrombotic Microangiopathy. Modern Pathology. 2025;38(4):100690. doi:10.1016/j.modpat.2024.100690

BibTeX
@article{vanDoorn2025,
  author = {van Doorn, Daan P C and Tobal, Rachid and Abdul-Hamid, Myrurgia A and van Paassen, Pieter and Timmermans, Sjoerd A M E G},
  title = {Etiology and Outcomes of Kidney-Limited and Systemic Thrombotic Microangiopathy},
  journal = {Modern Pathology},
  year = {2025},
  volume = {38},
  number = {4},
  pages = {100690},
  doi = {10.1016/j.modpat.2024.100690}
}
Kostenlos starten →